|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/225 | (2006.01) |
| A61K 31/41 | (2006.01) | ||
| A61P 9/04 | (2006.01) |
| (11) | Number of the document | 4212152 |
| (13) | Kind of document | T |
| (96) | European patent application number | 23154757.1 |
| Date of filing the European patent application | 2016-05-09 | |
| (97) | Date of publication of the European application | 2023-07-19 |
| (45) | Date of publication and mention of the grant of the patent | 2025-04-30 |
| (46) | Date of publication of the claims translation | 2025-07-10 |
| (30) | Number | Date | Country code |
| 201562159703 P | 2015-05-11 | US |
| (72) |
RIZKALA, Adel Redmond , US
SHI, Victor Chengwei , US
CHEN, Fabian , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Sakubitrilo ir valsartano dozavimo režimas, skirtas lėtinio sistolinio širdies nepakankamumo gydymui |
| SACUBITRIL-VALSARTAN DOSAGE REGIMEN FOR TREATING CHRONIC SYSTOLIC HEART FAILURE |
| Payment date | Validity (years) | Amount | |
| 2025-06-18 | 10 | 231.00 EUR |
| 2026-05-09 |